Alpha Mark Advisors, LLC Bio N Tech Se Transaction History
Alpha Mark Advisors, LLC
- $231 Million
- Q4 2024
A detailed history of Alpha Mark Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Alpha Mark Advisors, LLC holds 35 shares of BNTX stock, worth $4,331. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35
Previous 165
78.79%
Holding current value
$4,331
Previous $20,000
80.0%
% of portfolio
0.0%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BNTX
# of Institutions
360Shares Held
38.3MCall Options Held
2.45MPut Options Held
2.29M-
Baillie Gifford & CO8.22MShares$1.02 Billion0.74% of portfolio
-
Primecap Management CO Pasadena, CA4.52MShares$559 Million0.4% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.36MShares$540 Million2.05% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$235 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$224 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $30B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...